Characterization of Durable Responder for Capecitabine Monotherapy in Patients With Anthracycline- and Taxane-Pretreated Metastatic Breast Cancer
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference14 articles.
1. Multicentre, phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer;Fumoleau;Eur J Cancer,2004
2. Randomized phase III trial of ixabepilone plus capecitabine versus capecitabine in patients with metastatic breast cancer previously treated with an anthracycline and a taxane;Sparano;J Clin Oncol,2010
3. Lapatinib plus capecitabine for HER2-positive advanced breast cancer;Geyer;N Engl J Med,2006
4. Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results;O'Shaughnessy;J Clin Oncol,2002
5. Capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer;Lee;Med Oncol,2004
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effect of capecitabine as monotherapy for HER2 normal metastatic breast cancer;Medical Oncology;2024-03-27
2. Molecular tests for prediction of tumor sensitivity to cytotoxic drugs;Cancer Letters;2022-02
3. Detection of phenotype‐specific therapeutic vulnerabilities in breast cells using a CRISPR loss‐of‐function screen;Molecular Oncology;2021-05
4. Features of durable response and treatment efficacy for capecitabine monotherapy in advanced breast cancer: real-world evidence from a large single-centre cohort;Journal of Cancer Research and Clinical Oncology;2021-01-20
5. The role of capecitabine and eribulin in the treatment of metastatic HER2-negative metastatic breast cancer;Journal of Modern Oncology;2018-09-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3